United States · Investor

Advanced Technology Ventures

Last cheque observed Jan 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

SeedSeries ASeries BMedicinesPsychedelicsMrna

Cheques on record
0%of best year0cheques in 12 months, 156 on record
Since the last cheque2853days00hrs00min00sec
Median round$53MRounds led0 of 156Sole investor2 roundsExits26 from the portfolioMostly inUnited States, 98%
Pitch Advanced Technology Ventures

Advanced Technology Ventures highlights

  1. 01

    156 rounds on record

  2. 02

    Mostly Series C and Series B: 52% of its rounds

  3. 03

    Sole investor in 2 rounds, median $7.1M

  4. 04

    26 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Up to $5.0M as they say
Stages
SeedSeries ASeries BGrowthPre-IPO
Sectors
MedicinesPsychedelicsMrna
Based in
Menlo Park, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first156 appearances

  1. 2019

    1 round

  2. Jan
    GynesonicsUS · FinSMEs$75MWith 7 others
  3. 2018

    1 round

  4. Jul
    EndoGastricUS · FinSMEs$31MWith 6 others
  5. 2015

    2 rounds

  6. Dec
    EndoGastric SolutionsVenture · US$50MWith 5 others
  7. Jul
    GynesonicsGrowth · US$43MWith 5 others
  8. 2014

    8 rounds

  9. Nov
    Host AnalyticsSeries E · US$25MWith 4 others
  10. Jul
    GynesonicsDebt · US$28MWith 4 others
  11. May
    EvergageSeries A · US$4.0MWith 6 others
  12. May
    EndoGastric SolutionsSeries G · US$30MWith 6 others
  13. Apr
    HolairaSeries D · US$42MWith 5 others
  14. Mar
    ActifioSeries E · US$100MWith 4 others
  15. Mar
    Aquion EnergySeries D · US$57MWith 7 others
  16. Jan
    PowerVisionSeries D · US$20MWith 6 others
  17. 2013

    13 rounds

  18. Nov
    Catabasis PharmaceuticalsSeries B · US · finsmes.com$32MWith 4 others
  19. Oct
    Calithera BiosciencesSeries D · US · finsmes.com$35MWith 3 others
  20. Oct
    ThinkingPhonesSeries C · US · finsmes.com$10MWith 1 other
  21. Aug
    CoskataDebt · US$3.0MWith 5 others
  22. Aug
    Rive TechnologySeries D · US · finsmes.com$20MWith 5 others
  23. Jun
    Second GenomeSeries B · US · pevc.dowjones.com$12MWith 1 other
  24. Apr
    Aquion EnergySeries D · US · pehub.com$35MWith 5 others
  25. Apr
    Host AnalyticsVenture · US$6.5MWith 3 others
  26. Apr
    Solar JunctionVenture · US$8.1MSole investor
  27. Feb
    GynesonicsDebt · US · sec.gov$22MWith 4 others
  28. Feb
    Innovative Pulmonary SolutionsSeries C · US · finsmes.com$10MWith 3 others
  29. Feb
    Catabasis PharmaceuticalsVenture · US · fiercebiotech.com$9.0MWith 3 others
  30. Jan
    Host AnalyticsSeries D · US · techcrunch.com$17MWith 3 others
  31. 2012

    14 rounds

  32. Dec
    Calithera BiosciencesSeries C · US$2.0MWith 2 others
  33. Nov
    ModriaSeed · US · techcrunch.com$2.5MWith 5 others
  34. Oct
    ThrasosSeries C · CA · businesswire.com$35MWith 6 others
  35. Oct
    ThinkingPhonesVenture · US · finsmes.com$17MWith 1 other
  36. Sept
    Innovative Pulmonary SolutionsVenture · US · pevc.dowjones.com$11MWith 3 others
  37. Aug
    QuickPaySeed · US · techcrunch.com$3.5MWith 4 others
  38. Jun
    EndoGastric SolutionsSeries F · US · finsmes.com$13MWith 6 others
  39. May
    EvergageSeed · US · techcrunch.com$2.0MWith 4 others
  40. Apr
    EndPlaySeries C · US · finsmes.com$22MWith 1 other
  41. Apr
    EndoGastric SolutionsVenture · US$2.1MWith 6 others
  42. Apr
    Calithera BiosciencesVenture · US$4.0MWith 3 others
  43. Apr
    Second GenomeSeries A · US$2.5MWith 1 other
  44. Mar
    EndoGastric SolutionsSeries G · US · researchviews.com$11MWith 3 others
  45. Feb
    Solar JunctionSeries D · US · finsmes.com$19MWith 3 others
  46. 2011

    10 rounds

  47. Dec
    Catabasis PharmaceuticalsSeries A · US · catabasispharma.com$8.0MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration6 named

JMJean M. GeorgeDirector of Atv Capital ManagementiForm ADV
MAMichael A. CarusiPresident, Director of Atv Capital ManagementiForm ADV
RCRobert C. HowerDirector of Atv Capital ManagementiForm ADV
SNSteven Nicholas BaloffDirector of Atv Capital ManagementiForm ADV
TJTravis John BoettnerChief Financial OfficeriForm ADV
WCWilliam C. WibergVice President, Treasurer & Secretary, Director of Atv Capital ManagementiForm ADV

We also hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$25Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
ATV Capital Management, Inc.
SEC number
CRD 162341

Exits from the portfolio

Companies it backed that were later bought or listed26 in all

ActifioBought by GoogleUndisclosedDec 2020
TripwireBought by Belden$710MDec 2014
NuventixBought by Aavid ThermalloyUndisclosedJul 2014
CenzicBought by Trustwave HoldingsUndisclosedMar 2014
Five Prime TherapeuticsListedUndisclosedJul 2013
VerastemListed$52MJul 2013
ChannelAdvisorListed$81MMay 2013
Portola PharmaceuticalsListed$100MMay 2013
Aperio TechnologiesBought by Leica MicrosystemsUndisclosedAug 2012
QumuBought by Rimage$52MOct 2011
TripwireBought by Thoma BravoUndisclosedMay 2011
PlexxikonBought by Daiichi Sankyo$935MFeb 2011
ArdianBought by Medtronic$800MNov 2010
Integrated Media Measurement (IMMI)Bought by ArbitronUndisclosedJun 2010
OmneonBought by Harmonic$274MMay 2010
HelixisBought by IlluminaUndisclosedApr 2010
HandangoBought by AppiaUndisclosedFeb 2010
EngageBought by Spark NetworksUndisclosedApr 2009
CompassoftBought by Finsbury SolutionsUndisclosedFeb 2009
Liquid EnginesBought by Thomson ReutersUndisclosedAug 2008

The latest 20 here. An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Advanced Technology Ventures. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Advanced Technology Ventures

What does Advanced Technology Ventures invest in?

Advanced Technology Ventures invests most often at Series C and Series B (52% of the rounds on record), in sectors such as Medicines, Psychedelics and Mrna.

How active is Advanced Technology Ventures?

156 investments on record, 0 of them in the last 12 months. The most recent was in Jan 2019.

What has Advanced Technology Ventures invested in recently?

Its most recent investments on record: Gynesonics (Undisclosed round, Jan 2019) and EndoGastric (Undisclosed round, Jul 2018).

How big are Advanced Technology Ventures's cheques?

The median round it joins is $53M.

Does Advanced Technology Ventures lead rounds?

Rarely, if at all: none of its 156 investments on record names it as the lead.

Where does Advanced Technology Ventures invest?

Most of the companies it backs are in the United States (98%).

Is Advanced Technology Ventures investing now?

No investments in the last 12 months; the latest was in Jan 2019.

Who does Advanced Technology Ventures invest alongside?

Most often Morgenthaler Ventures (18 rounds together), Foundation Medical Partners (11 rounds together) and MPM Capital (11 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it